Fischer Corinne E, Golas Angela C, Schweizer Tom A, Munoz David G, Ismail Zahinoor, Qian Winnie, Tang-Wai David F, Rotstein Dalia L, Day Gregory S
a Keenan Research Centre for Biomedical Research , Li Ka Shing Knowledge Institute, St. Michael's Hospital , Toronto , ON , Canada.
b Institute of Medical Sciences , University of Toronto , Toronto , ON , Canada.
Expert Rev Neurother. 2016 Jul;16(7):849-59. doi: 10.1080/14737175.2016.1184088. Epub 2016 May 17.
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an inflammatory disorder of the brain that has garnered significant interest within the medical and lay communities. There is a need for formal guidelines to assist physicians in identifying patients who should undergo testing for NMDAR encephalitis, recognizing the high potential for this potentially treatable disease to mimic more common disorders, and consequently remain undiagnosed.
This review highlights the impact of the discovery of NMDAR encephalitis on the fields of neurology and psychiatry, and discusses the steps that are necessary to improve recognition and treatment of NMDAR encephalitis. Expert commentary: While much progress has been made in our understanding of NMDAR encephalitis, much work remains to be done to delineate the underlying disease mechanisms and their relevance to brain function.
抗N-甲基-D-天冬氨酸受体(NMDAR)脑炎是一种脑部炎症性疾病,在医学界和普通大众中引起了广泛关注。由于这种潜在可治疗的疾病很可能被误诊为更常见的疾病而无法确诊,因此需要正式的指南来帮助医生识别应接受NMDAR脑炎检测的患者。
本综述强调了NMDAR脑炎的发现对神经病学和精神病学领域的影响,并讨论了提高NMDAR脑炎识别和治疗水平所需的步骤。专家评论:虽然我们对NMDAR脑炎的理解已经取得了很大进展,但在阐明潜在的疾病机制及其与脑功能的相关性方面仍有许多工作要做。